Skip to content
Medical Health Aged Care, Women

Helping nurses lift much-needed access to sexual and reproductive health care in rural and regional areas

Monash University 3 mins read

An innovative co-designed model of care to help elevate the role of nurses in contraceptive and medical abortion care in rural and regional areas has been developed as part of the landmark ORIENT study.

 

Development of the Monash University-led model is an important step in addressing chronic lack of access to contraceptive and medical abortion care in regional and rural communities in Australia.

 

Women living in regional or remote areas are 1.4 times more likely to experience an unintended pregnancy than women living in non-rural settings.* For some, accessing services means travelling more than four hours due to the very limited number of primary care providers available.**

A paper describing this new  model of care for general practices has been published in the Journal of Advanced Nursing.

The
Head of Monash University’s Department of General Practice, Professor Danielle Mazza AM, said the paper, prepared by researchers from the SPHERE Centre of Research Excellence at Monash University, was an important contribution to the body of knowledge needed to elevate the role of nurses in delivery of sexual and reproductive health care.

“It is especially timely with the Federal Government’s independent Unleashing the Potential of our Health Workforce Scope of Practice Review underway, and matches a growing international trend that recognises the potential of nurses in delivering contraception and medical abortion care,” Professor Mazza said.

A wide range of issues contributes to the current scarcity of services in rural and regional Australia, such as a shortage of GPs and health services in general, stigma, lack of available training, and lack of awareness of some of the most effective forms of contraception such as Long Acting Reversible Contraception (LARC), including intrauterine devices (IUDs) and the contraceptive implant.

The co-design process for development of the new model of care, led by PhD Candidate Jessica Moulton, with rural and regional nurses and GPs, and patients, focused on how the model could work in general practices, how patients would access the services and the roles of GPs, practice nurses, receptionists and practice managers.

The ORIENT study, which involves nurses gaining the knowledge and skills to insert contraceptive devices and support delivery of medical abortion care, will test the effectiveness and cost effectiveness of the co-designed model of care. It is due to be completed by the end of 2025. 

“Many nurses working in general practice settings have an interest in women's health and a lot of them want to provide these services,” Professor Mazza said.

“The Therapeutic Goods Administration has recently removed restrictions on prescribing and dispensing the medical abortion pill MS-2 Step. The government has also made budget commitments to support primary care practitioners to train in LARC insertion”.

“Nurses are poised to work to their full scope of practice to include the provision of LARC and medical abortion. But greater support is needed to facilitate this in Australia and ensure equitable access to sexual and reproductive health services, particularly for those living in regional and remote areas. This includes training, remuneration and legislative change to enable prescribing,” Professor Mazza said.

Some of the key features of the codesigned model of care for the ORIENT study include:

  • establishing an appropriate and effective booking service
  • a website that provides support with information and discrete access
  • blocking off appointments for medical abortion on a weekly or daily basis to ensure patients are seen in a timely manner
  • training reception staff to ensure sensitive responses to inquiries without stigma, judgement or delays, and understand issues around culture and diversity 
  • fostering good relationships with other professionals involved in care including pharmacists, pathology, radiology and emergency care, especially where there are limited services
  • having adequate stocks of implant/MS2-Step in clinic where possible

Thirty two regional general practices have joined the ORIENT study. When the study ends in 2025, the research team will compare the services delivered at each practice before and after the nurse-led approach began.

The Medical Research Future Fund funded the ORIENT Study with a grant of $1.92 million.

Read the full paper in the Journal of Nursing: Wiley Online Library: A nurse‐led model of care to improve access to contraception and abortion in rural general practice: Co‐design with consumers and providers. DOI: 10.1111/jan.16299


** (Shankar et al., 2017)  (Subasinghe et al., 2021).


For media enquiries please contact: Monash University

Cheryl Critchley – Media and Communications Manager (medical)
E: [email protected] 

T: +61 (0) 477 571 442

For more Monash media stories, visit our news and events site  


For general media enquiries please contact: Monash Media
E: [email protected]
T: +61 (0) 3 9903 4840

***ENDS***

More from this category

  • Medical Health Aged Care
  • 09/01/2026
  • 23:40
Dark Horse Consulting Group

Bruder Consulting & Venture Group to become Dark Horse Consulting Regenerative Medicine

WALNUT CREEK, Calif. and NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Dark Horse Consulting Group (“DHCG” or “the Group”), a leader in strategic and operational biotherapeutics consulting, is pleased to announce the acquisition of Bruder Consulting & Venture Group (“Bruder” or “BCVG”), a strategic advisory and consulting firm with a global footprint in biotech and biopharma, known for their expertise in the discovery, development, clinical design, and regulatory approval process of biologics, devices and combination products in the orthopedic, wound care, and plastic & reconstructive surgery markets. BCVG is now a department within Dark Horse Consulting (DHC) known as…

  • Medical Health Aged Care
  • 09/01/2026
  • 23:11
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)

Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs   BEIJING & ALAMEDA, Calif.…

  • Contains:
  • Medical Health Aged Care
  • 09/01/2026
  • 17:11
MRM Health NV

MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis

MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.